SCHEMBL10183227

SCHEMBL10183227

O=C1C(N(C(=O)Cc2c[nH]c3ccccc23)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MC4R P32245 1/20 0.41
▸ MC5R P33032 1/20 0.41
▸ MC3R P41968 1/20 0.41
▸ HTR1A P08908 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ POLB P06746 3/20 0.38
▸ TP53 P04637 2/20 0.37
▸ AGTR2 P50052 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ OPRL1 P41146 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ SSTR3 P32745 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183922 0.91 HTR1A (0.36) MAPTMEN1KMT2AMC4RMC5R
SCHEMBL10183925 0.83 TP53 (0.41) MAPTMEN1KMT2APOLBTP53
SCHEMBL10185583 0.83 OPRM1 (0.35) MAPTMEN1KMT2AHTR1ADRD2
SCHEMBL10183299 0.83 OPRM1 (0.40) MAPTTP53AGTR2OPRM1OPRK1
SCHEMBL10183337 0.82 OPRM1 (0.39) MAPTMEN1KMT2ATP53AGTR2
SCHEMBL10183319 0.82 MEN1 (0.43) MAPTMEN1KMT2ATP53AGTR2
SCHEMBL10185857 0.82 SLC6A2 (0.38) MAPTOPRM1OPRK1OPRL1KDM4E
SCHEMBL10183321 0.82 OPRM1 (0.37) MAPTMEN1KMT2ATP53AGTR2
SCHEMBL10184119 0.81 OPRM1 (0.37) MAPTPOLBTP53AGTR2OPRM1
SCHEMBL10185926 0.80 OPRM1 (0.39) MAPTPOLBTP53AGTR2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback